Association between pulmonary function and renal function: findings from China and Australia

Abstract

BackgroundThe relationship between obstructive lung function and impaired renal function is unclear. This study investigated the dose-response relationship between obstructive lung function and impaired renal function.MethodsTwo independent cross-sectional studies with representative sampling were applied. 1454 adults from rural Victoria, Australia (1298 with normal renal function, 156 with impaired renal function) and 5824 adults from Nanjing, China (4313 with normal renal function, 1511 with impaired renal function). Pulmonary function measurements included forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Estimated glomerular filtration rate (eGFR), and impaired renal function marked by eGFR <60 mL/min/1.73m2 were used as outcome.ResultseGFR increased linearly with FEV1 in Chinese participants and with FVC in Australians. A non-linear relationship with peaked eGFR was found for FEV1 at 2.65 L among Australians and for FVC at 2.78 L among Chinese participants, respectively. A non-linear relationship with peaked eGFR was found for the predicted percentage value of forced expiratory volume in 1 s (PFEV1) at 81–82% and for the predicted percentage value of forced vital capacity (PFVC) at 83–84% among both Chinese and Australian participants, respectively.The non-linear dose-response relationships between lung capacity measurements (both for FEV1 and FVC) and risk of impaired renal function were consistently identified in both Chinese and Australian participants. An increased risk of impaired renal function was found below 3.05 L both for FEV1 and FVC, respectively. The non-linear relationship between PFEV and PVC and the risk of impaired renal function were consistently identified in both Chinese and Australian participants. An increased risk of impaired renal function was found below 76–77% for PFEV1 and 79–80% for PFVC, respectively.ConclusionsIn both Australian and Chinese populations, the risk of impaired renal function increased both with FEV1 and FVC below 3.05 L, with PFEV1 below 76–77% or with PFVC below 79–80%, respectively. Obstructive lung function was associated with increased risk of reduced renal function. The screen for impaired renal function in patients with obstructive lung disease might be useful to ensure there was no impaired renal function before the commencement of potentially nephrotoxic medication where indicated (eg diuretics).Electronic supplementary materialThe online version of this article (doi:10.1186/s12882-017-0565-y) contains supplementary material, which is available to authorized users.

Dose-response association between physical activity and clustering of modifiable cardiovascular risk factors among 26,093 Chinese adults

“…Study participants' height was measured to the nearest 10th of a centimeter without wearing shoes. Both in Nanjing and Hefei surveys, above measurements were made by trained observers who were all asked to attend a training session to learn the standardized protocol of measurement techniques [8]. Study participants' body mass index was calculated by their body weight (unit: kg) divided by the square of their height (unit: meter).…”

Association between serum creatinine levels and pulmonary function of Korean adults: the 2016-2019 Korea National Health and Nutrition Examination Survey

“…In a study comprising 1246 men, Jung et al [ 14 ] revealed that male smokers had lower FEV1 and FVC in cases of albuminuria. Yu et al [ 16 ] found that in a cohort comprising 1454 Australian and 5824 Chinese individuals, an increased risk of reduced renal function was related to obstructive lung function, and that FEV1 and FVC < 3.05 L increased the risk of impaired renal function. A small Japanese study also reported that reduced GFR is associated with reduced pulmonary diffusing capacity [ 17 ].…”

Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes

“…When we compared the functional trend in the CLAD and in the non-CLAD groups, the only statistically significant difference was found in the 12th month: %∆FVC; FEV 1 and FVC progressively increased in the non-CLAD group, probably due to ameliorative effects of everolimus on renal function; indeed it has been demonstrated that there is a non-linear dose-relationship between eGFR and FEV 1 and FVC. 20 In patients with chronic kidney disease, fluid overload together with increased pulmonary capillary permeability are closely associated with restrictive and obstructive respiratory abnormalities, as demonstrated in patients who underwent hemodialysis. 21 Even in the CLAD group, we observed a non-statistically significant and transient improvement of both FEV 1 and FVC after 1 month, but, subsequently, these parameters worsened.…”